Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:18 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 1,133,944 17.700% |
175,019 (+18.25%) |
Filing History |
| 2025-02-14 4:33 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 640,770 9.990% |
640,770 (New Position) |
Filing History |
| 2025-02-14 4:22 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
ORBIMED ADVISORS LLC | 510,000 8.000% |
510,000 (New Position) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
PERCEPTIVE ADVISORS LLC | 163,935 2.500% |
12,502 (+8.26%) |
Filing History |
| 2025-02-14 4:11 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 643,622 9.990% |
643,622 (New Position) |
Filing History |
| 2025-02-14 1:15 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Ikarian Capital LLC | 609,225 9.500% |
609,225 (New Position) |
Filing History |
| 2025-02-14 11:25 am Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
JANUS HENDERSON GROUP PLC JHG |
690,743 10.000% |
690,743 (New Position) |
Filing History |
| 2025-02-13 11:20 am Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Boothbay Fund Management LLC | 88,785 6.000% |
88,785 (New Position) |
Filing History |
| 2025-02-10 12:47 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
FARALLON CAPITAL PARTNERS LP | 221,027 3.400% |
69,287 (+45.66%) |
Filing History |
| 2025-01-10 8:13 pm Purchase |
2024-11-20 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 432,276 6.760% |
432,276 (New Position) |
Filing History |
| 2024-12-06 4:05 pm Purchase |
2024-11-30 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 958,925 15.000% |
876,227 (+1059.55%) |
Filing History |
| 2024-11-14 4:31 pm Purchase |
2024-09-30 | 13G | Forte Biosciences, Inc. FBRX |
PERCEPTIVE ADVISORS LLC | 151,433 9.990% |
151,433 (New Position) |
Filing History |
| 2024-11-14 4:02 pm Purchase |
2024-09-30 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 82,698 5.700% |
82,698 (New Position) |
Filing History |
| 2024-06-17 06:24 am Sale |
2024-06-14 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 58,480 4.000% |
-4,607 (-7.30%) |
Filing History |
| 2024-02-14 4:56 pm Purchase |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
PERCEPTIVE ADVISORS LLC | 145,345 9.900% |
234 (+0.16%) |
Filing History |
| 2024-02-14 4:54 pm Purchase |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 145,219 9.990% |
145,219 (New Position) |
Filing History |
| 2024-02-14 4:11 pm Unchanged |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 73,559 5.100% |
0 (Unchanged) |
Filing History |
| 2024-02-14 09:33 am Purchase |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
FARALLON CAPITAL PARTNERS LP | 151,740 9.900% |
234 (+0.15%) |
Filing History |
| 2024-01-10 5:39 pm Purchase |
2024-01-10 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 70,468 4.800% |
1,065 (+1.53%) |
Filing History |
| 2024-01-08 6:17 pm Unchanged |
2023-07-06 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 81,279 5.590% |
0 (Unchanged) |
Filing History |